0001445499-19-000001.txt : 20190222 0001445499-19-000001.hdr.sgml : 20190222 20190222145013 ACCESSION NUMBER: 0001445499-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190222 DATE AS OF CHANGE: 20190222 EFFECTIVENESS DATE: 20190222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC CENTRAL INDEX KEY: 0001445499 IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333369 FILM NUMBER: 19625261 BUSINESS ADDRESS: STREET 1: 915 EAST PINE ST STREET 2: SUITE 401 CITY: SEATTLE STATE: WA ZIP: 98122 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 915 EAST PINE ST STREET 2: SUITE 401 CITY: SEATTLE STATE: WA ZIP: 98122 D 1 primary_doc.xml X0708 D LIVE 0001445499 IMPEL NEUROPHARMA INC 201 Elliott Ave. W, Suite 260 SEATTLE WA WASHINGTON 98119 206-568-1466 DELAWARE None None Corporation true John D. Hoekman c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Executive Officer Director Stewart Parker c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Aaron Royston c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Mahendra Shah c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Jim Young c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Jon Congleton c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Executive Officer Director Robert Mittendorff c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Tim Nelson c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Ali Satvat c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Other Health Care Decline to Disclose 06b false 2019-02-08 false true true false 0 1387323 0 1387323 Represents securities offered under an equity incentive plan. false 4 0 0 0 false IMPEL NEUROPHARMA INC /s/ Jon Congleton Jon Congleton President and CEO 2019-02-22